,
Suda, Goki
Hasebe, Chitomi
Abe, Masami
Kurosaki, Masayuki
Itakura, Jun
Izumi, Namiki
Uchida, Yoshihito
Mochida, Satoshi
Haga, Hiroaki
Ueno, Yoshiyuki
Abe, Kazumichi
Takahashi, Atsushi
Ohira, Hiromasa
Tsukuda, Yoko
Furuya, Ken
Baba, Masaru
Yamamoto, Yoshiya
Kobayashi, Tomoe
Inoue, Jun
Terasita, Katsumi
Ohara, Masatsugu
Kawagishi, Naoki
Izumi, Takaaki
Nakai, Masato
Sho, Takuya
Natsuizaka, Mitsuteru
Morikawa, Kenichi
Ogawa, Koji
Sakamoto, Naoya
Funding for this research was provided by:
AMED (18fk0210002h0003, JP18fk0210018h0002)
KAKEN (16K09334)
Article History
Received: 13 November 2018
Accepted: 4 February 2019
First Online: 18 February 2019
Compliance with ethical standards
:
: Professor Naoya Sakamoto has received lecture fees from Bristol Myers Squibb, and Pharmaceutical K.K., grants and endowments from MSD, K. K. and Chugai Pharmaceutical Co., Ltd, and a research grant from Gilead Sciences Inc and AbbVie GK. Dr. Goki Suda has received research grants from Merck & Co and Bristol Myers Squibb. Dr. Masayuki Kurosaki received lecture fee from Abbvie GK and Gilead Sciences. Dr. Yoshihito Uchida has received research grant from AbbVie GK. Professor Satoshi Mochida has received speaking fees or honoraria from AbbVie GK, Ajinomoto Pharmaceuticals Co. Ltd., Bristol Myers Squibb Co., Gilead Sciences Inc., MSD K.K., Sumitomo Dainippon Pharma Co., Toray Medical Co. Ltd., has received research grants from A2 Healthcare Co., AbbVie GK, Bristol Myers Squibb Co., Chugai Pharmaceutical Co. Ltd., EA Pharma Co. Ltd., Mitsubishi Tanabe Pharma Co., MSD K.K., Sumitomo Dainippon Pharma Co., Toray Medical Co. Ltd., has received patent royalties from SRL Inc. Dr. Hiroaki Haga has received grants and endowments from Gilead Sciences. Professor Yoshiyuki Ueno has received grants and endowments from Gilead Sciences, MSD K.K., and AbbVie GK.Dr Ikuto Masakane has received lecture fee from Bristol Myers Squibb and AbbVie GK. The other authors have no conflicts of interest to disclose.